OBJECTIVE： To provide suggestions for pharmaceutical manufacturers to improve medicine package in China. METHODS： The problems of some Chinese patent medicine package were summed up and analyzed， and improvement suggestions were put forward. RESULTS & CONCLUSIONS： At present， many defects are observed in Chinese patent drug package， such as large package increasing patients’ burden； various package material aggravating resource waste and environmental pollution； individual package and multilayered package increasing unpacking and peeling time， and bringing risk； non-standard medicine information carrier easily resulting in medical errors. Pharmaceutical manufacturers are suggested to simplify drug package， increase package capacity， adopt ordinary packagdized， highlight key information and other measures. Through these measures， Chinese patent medicine package could to be more standard， humanized and be convenient for clinical use.